{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T22:46:58Z","timestamp":1785192418824,"version":"3.55.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T00:00:00Z","timestamp":1635465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T00:00:00Z","timestamp":1635465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s11255-021-03044-w","type":"journal-article","created":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T13:03:54Z","timestamp":1635512634000},"page":"9-16","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["The influence of gut microbiome on progression of overactive bladder symptoms: a community-based 3-year longitudinal study in Aomori, Japan"],"prefix":"10.1007","volume":"54","author":[{"given":"Yoshiharu","family":"Okuyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3750-3811","authenticated-orcid":false,"given":"Teppei","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daichi","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Ozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung","family":"Songee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Hatakeyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Mikami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikara","family":"Ohyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,29]]},"reference":[{"issue":"3","key":"3044_CR1","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1159\/000447205","volume":"11","author":"E Leron","year":"2018","unstructured":"Leron E, Weintraub AY, Mastrolia SA, Schwarzman P (2018) Overactive bladder syndrome: evaluation and management. Curr Urol 11(3):117\u2013125. https:\/\/doi.org\/10.1159\/000447205","journal-title":"Curr Urol"},{"issue":"6","key":"3044_CR2","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1177\/0884533615609896","volume":"30","author":"GM Barlow","year":"2015","unstructured":"Barlow GM, Yu A, Mathur R (2015) Role of the gut microbiome in obesity and diabetes mellitus. Nutr Clin Pract 30(6):787\u2013797. https:\/\/doi.org\/10.1177\/0884533615609896","journal-title":"Nutr Clin Pract"},{"key":"3044_CR3","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002699","author":"J Yin","year":"2015","unstructured":"Yin J, Liao S-X, He Y et al (2015) Dysbiosis of gut microbiota with reduced trimethylamine-N-Oxide level in patients with large-artery atherosclerotic stroke or transient ischemic attack. J Am Heart Assoc. https:\/\/doi.org\/10.1161\/JAHA.115.002699","journal-title":"J Am Heart Assoc"},{"issue":"8","key":"3044_CR4","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1007\/s11255-018-1873-2","volume":"50","author":"M Kanbay","year":"2018","unstructured":"Kanbay M, Onal EM, Afsar B et al (2018) The crosstalk of gut microbiota and chronic kidney disease: role of inflammation, proteinuria, hypertension, and diabetes mellitus. Int Urol Nephrol 50(8):1453\u20131466. https:\/\/doi.org\/10.1007\/s11255-018-1873-2","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"3044_CR5","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1159\/000512167","volume":"102","author":"H Matsumoto","year":"2021","unstructured":"Matsumoto H, Shiotani A, Katsumata R et al (2021) Mucosa-associated microbiota in patients with irritable bowel syndrome: a comparison of subtypes. Digestion 102(1):49\u201356. https:\/\/doi.org\/10.1159\/000512167","journal-title":"Digestion"},{"key":"3044_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-020-03243-7","author":"T Okamoto","year":"2020","unstructured":"Okamoto T, Hatakeyama S, Imai A et al (2020) Altered gut microbiome associated with overactive bladder and daily urinary urgency. World J Urol (Published Online). https:\/\/doi.org\/10.1007\/s00345-020-03243-7","journal-title":"World J Urol (Published Online)"},{"issue":"6","key":"3044_CR7","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo S, Imai E, Horio M et al (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53(6):982\u2013992. https:\/\/doi.org\/10.1053\/j.ajkd.2008.12.034","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"3044_CR8","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1111\/j.1572-0241.2008.02066.x","volume":"103","author":"M Kanazawa","year":"2008","unstructured":"Kanazawa M, Palsson OS, Thiwan SIM et al (2008) Contributions of pain sensitivity and colonic motility to IBS symptom severity and predominant bowel habits. Am J Gastroenterol 103(10):2550\u20132561. https:\/\/doi.org\/10.1111\/j.1572-0241.2008.02066.x","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"3044_CR9","first-page":"441","volume":"48","author":"M Urashima","year":"2005","unstructured":"Urashima M, Wada T, Fukumoto T et al (2005) Prevalence of metabolic syndrome in a 22, 892 Japanese Population and Japan. Med Assoc J 48(9):441\u2013450","journal-title":"Med Assoc J"},{"key":"3044_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2018.04.017","author":"K Kido","year":"2018","unstructured":"Kido K, Hatakeyama S, Imai A et al (2018) Sleep disturbance has a higher impact on general and mental quality of life reduction than nocturia: results from the community health survey in Japan. Eur Urol Focus. https:\/\/doi.org\/10.1016\/j.euf.2018.04.017","journal-title":"Eur Urol Focus"},{"issue":"3","key":"3044_CR11","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1177\/014662167700100306","volume":"1","author":"LS Radloff","year":"1977","unstructured":"Radloff LS (1977) The CES-D scale. Appl Psychol Meas 1(3):385\u2013401. https:\/\/doi.org\/10.1177\/014662167700100306","journal-title":"Appl Psychol Meas"},{"issue":"5","key":"3044_CR12","doi-asserted-by":"publisher","first-page":"e0155431","DOI":"10.1371\/journal.pone.0155431","volume":"11","author":"G Vilagut","year":"2016","unstructured":"Vilagut G, Forero CG, Barbaglia G, Alonso J (2016) Screening for depression in the general population with the center for epidemiologic studies depression (CES-D): a systematic review with meta-analysis. PLoS ONE 11(5):e0155431. https:\/\/doi.org\/10.1371\/journal.pone.0155431","journal-title":"PLoS ONE"},{"issue":"2","key":"3044_CR13","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.urology.2006.02.042","volume":"68","author":"Y Homma","year":"2006","unstructured":"Homma Y, Yoshida M, Seki N et al (2006) Symptom assessment tool for overactive bladder syndrome\u2014overactive bladder symptom score. Urology 68(2):318\u2013323. https:\/\/doi.org\/10.1016\/j.urology.2006.02.042","journal-title":"Urology"},{"key":"3044_CR14","doi-asserted-by":"publisher","DOI":"10.1111\/bju.14972","author":"B Holland","year":"2019","unstructured":"Holland B, Karr M, Delfino K et al (2019) The effect of the urinary and fecal microbiota on lower urinary tract symptoms measured by the international prostate symptom score: analysis utilizing next-generation sequencing. BJU Int. https:\/\/doi.org\/10.1111\/bju.14972","journal-title":"BJU Int"},{"issue":"22","key":"3044_CR15","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.3748\/wjg.v25.i22.2706","volume":"25","author":"G Bruno","year":"2019","unstructured":"Bruno G, Zaccari P, Rocco G et al (2019) Proton pump inhibitors and dysbiosis: Current knowledge and aspects to be clarified. World J Gastroenterol 25(22):2706\u20132719. https:\/\/doi.org\/10.3748\/wjg.v25.i22.2706","journal-title":"World J Gastroenterol"},{"issue":"10","key":"3044_CR16","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1111\/apt.12069","volume":"36","author":"CPC De Jager","year":"2012","unstructured":"De Jager CPC, Wever PC, Gemen EFA et al (2012) Proton pump inhibitor therapy predisposes to community-acquired Streptococcus pneumoniae pneumonia. Aliment Pharmacol Ther 36(10):941\u2013949. https:\/\/doi.org\/10.1111\/apt.12069","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"3044_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-48352-5","volume":"9","author":"A Horvath","year":"2019","unstructured":"Horvath A, Rainer F, Bashir M et al (2019) Biomarkers for oralization during long-term proton pump inhibitor therapy predict survival in cirrhosis. Sci Rep 9(1):1\u20139. https:\/\/doi.org\/10.1038\/s41598-019-48352-5","journal-title":"Sci Rep"},{"issue":"1","key":"3044_CR18","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41467-017-00900-1","volume":"8","author":"Z Jie","year":"2017","unstructured":"Jie Z, Xia H, Zhong S-L et al (2017) The gut microbiome in atherosclerotic cardiovascular disease. Nat Commun 8(1):845. https:\/\/doi.org\/10.1038\/s41467-017-00900-1","journal-title":"Nat Commun"},{"issue":"1","key":"3044_CR19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1053\/j.gastro.2019.03.049","volume":"157","author":"R Pittayanon","year":"2019","unstructured":"Pittayanon R, Lau JT, Yuan Y et al (2019) Gut Microbiota in patients with irritable bowel syndrome-a systematic review. Gastroenterology 157(1):97\u2013108. https:\/\/doi.org\/10.1053\/j.gastro.2019.03.049","journal-title":"Gastroenterology"},{"issue":"4","key":"3044_CR20","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1111\/j.1464-410X.2012.11591.x","volume":"111","author":"S Matsumoto","year":"2013","unstructured":"Matsumoto S, Hashizume K, Wada N et al (2013) Relationship between overactive bladder and irritable bowel syndrome: a large-scale internet survey in Japan using the overactive bladder symptom score and Rome III criteria. BJU Int 111(4):647\u2013652. https:\/\/doi.org\/10.1111\/j.1464-410X.2012.11591.x","journal-title":"BJU Int"},{"issue":"3","key":"3044_CR21","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.pain.2006.09.023","volume":"128","author":"JA Christianson","year":"2007","unstructured":"Christianson JA, Liang R, Ustinova EE et al (2007) Convergence of bladder and colon sensory innervation occurs at the primary afferent level. Pain 128(3):235\u2013243. https:\/\/doi.org\/10.1016\/j.pain.2006.09.023","journal-title":"Pain"},{"issue":"2","key":"3044_CR22","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jinf.2020.05.027","volume":"81","author":"OB Esan","year":"2020","unstructured":"Esan OB, Perera R, McCarthy N, Violato M, Fanshawe TR (2020) Incidence, risk factors, and health service burden of sequelae of campylobacter and non-typhoidal salmonella infections in England, 2000\u20132015: a retrospective cohort study using linked electronic health records. J Infect 81(2):221\u2013230. https:\/\/doi.org\/10.1016\/j.jinf.2020.05.027","journal-title":"J Infect"},{"issue":"1","key":"3044_CR23","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1136\/gut.28.1.96","volume":"28","author":"CW Howden","year":"1987","unstructured":"Howden CW, Hunt RH (1987) Relationship between gastric secretion and infection. Gut 28(1):96\u2013107. https:\/\/doi.org\/10.1136\/gut.28.1.96","journal-title":"Gut"},{"key":"3044_CR24","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.06.075","author":"JL Wallace","year":"2011","unstructured":"Wallace JL, Syer S, Denou E et al (2011) Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis. Gastroenterology. https:\/\/doi.org\/10.1053\/j.gastro.2011.06.075","journal-title":"Gastroenterology"},{"issue":"8","key":"3044_CR25","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1185\/03007990903035745","volume":"25","author":"WD Chey","year":"2009","unstructured":"Chey WD, Mody RR, Wu EQ et al (2009) Treatment patterns and symptom control in patients with GERD: US community based survey. Curr Med Res Opin 25(8):1869\u20131878. https:\/\/doi.org\/10.1185\/03007990903035745","journal-title":"Curr Med Res Opin"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-021-03044-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-021-03044-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-021-03044-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T11:39:43Z","timestamp":1641382783000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-021-03044-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,29]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["3044"],"URL":"https:\/\/doi.org\/10.1007\/s11255-021-03044-w","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,29]]},"assertion":[{"value":"18 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Written informed consent was obtained from all subjects. The data we used from the Iwaki Health Promotion Project was approved by the Ethics Committee of Hirosaki University School of Medicine (authorization number 2021-003raH).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}